Profile: Wockhardt Ltd (WCKH.BO)

WCKH.BO on Bombay Stock Exchange

827.45INR
20 Nov 2014
Price Change (% chg)

Rs7.50 (+0.91%)
Prev Close
Rs819.95
Open
Rs828.10
Day's High
Rs844.50
Day's Low
Rs822.60
Volume
266,319
Avg. Vol
387,116
52-wk High
Rs886.50
52-wk Low
Rs336.60

Search Stocks
Wockhardt Limited is a pharmaceutical and biotechnology Company. The Company offers care in cardiology, cardiac surgery, neurology, neurosurgery, orthopedics and joint replacement surgery. Other specialities include minimal access surgery, nephrology, urology, critical care, medical and surgical oncology and emergency services and trauma care. The Company has also developed products for Abbreviated New Drug Applications (ANDAs), for the United States and European markets. The Company’s product includes Ace Proxyvon, Aceroc, Alphadopa, Aziwok, B.G.Prot and Bio-Corneum. The Company’s subsidiaries include Wockhardt Biopharm Limited, Vinton Healthcare Limited, Wockhardt Infrastructure Development Limited, Wockhardt UK Holdings Limited, Wockhardt Bio AG and Wockhardt Europe Limited.

Company Address

Wockhardt Ltd

Wockhardt Towers
Bandra Kurla Complex, Bandra (Ea
Bandra (East)
MUMBAI     400051
P: +9122.26534444
F: +9122.26534242

Company Web Links

Search Stocks